| 标题 |
Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials |
| 网址 | |
| DOI | |
| 其它 |
期刊:British Journal of Dermatology 作者:Andrew Blauvelt; Jacob P. Thyssen; Emma Guttman‐Yassky; Thomas Bieber; E. Serra‐Baldrich; et al 出版日期:2023-03-30 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)